vs
Side-by-side financial comparison of ASHFORD HOSPITALITY TRUST INC (AHT) and Protagonist Therapeutics, Inc (PTGX). Click either name above to swap in a different company.
ASHFORD HOSPITALITY TRUST INC is the larger business by last-quarter revenue ($259.0M vs $170.6M, roughly 1.5× Protagonist Therapeutics, Inc). Protagonist Therapeutics, Inc runs the higher net margin — 77.2% vs -26.8%, a 103.9% gap on every dollar of revenue. On growth, Protagonist Therapeutics, Inc posted the faster year-over-year revenue change (184.4% vs -6.0%). Protagonist Therapeutics, Inc produced more free cash flow last quarter ($182.8M vs $-86.8M).
Ashford Hospitality Trust Inc is a U.S.-headquartered real estate investment trust focused on upper-upscale full-service hotel properties across key U.S. urban, suburban and resort markets. Its portfolio holds assets under top global hospitality brands, serving business and leisure travelers, with a focus on long-term value growth and stable shareholder returns.
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel peptide-based targeted therapies for unmet medical needs, primarily covering gastrointestinal disorders, inflammatory diseases and rare disease indications. Its lead product candidates target inflammatory bowel disease and other chronic immune-related conditions, with operations spanning global R&D and partnership collaborations.
AHT vs PTGX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $259.0M | $170.6M |
| Net Profit | $-69.3M | $131.7M |
| Gross Margin | — | — |
| Operating Margin | -2.6% | 74.3% |
| Net Margin | -26.8% | 77.2% |
| Revenue YoY | -6.0% | 184.4% |
| Net Profit YoY | 44.2% | 381.7% |
| EPS (diluted) | $-12.85 | $2.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $259.0M | — | ||
| Q3 25 | $266.1M | — | ||
| Q2 25 | $302.0M | — | ||
| Q1 25 | $277.4M | — | ||
| Q4 24 | $275.5M | $170.6M | ||
| Q3 24 | $276.6M | — | ||
| Q2 24 | $316.5M | — | ||
| Q1 24 | $303.9M | $255.0M |
| Q4 25 | $-69.3M | — | ||
| Q3 25 | $-60.1M | — | ||
| Q2 25 | $-30.4M | — | ||
| Q1 25 | $-20.0M | — | ||
| Q4 24 | $-124.2M | $131.7M | ||
| Q3 24 | $-57.9M | — | ||
| Q2 24 | $50.3M | — | ||
| Q1 24 | $71.6M | $207.3M |
| Q4 25 | -2.6% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 16.3% | — | ||
| Q1 25 | 22.2% | — | ||
| Q4 24 | -17.8% | 74.3% | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 42.8% | — | ||
| Q1 24 | 50.2% | 80.9% |
| Q4 25 | -26.8% | — | ||
| Q3 25 | -22.6% | — | ||
| Q2 25 | -10.1% | — | ||
| Q1 25 | -7.2% | — | ||
| Q4 24 | -45.1% | 77.2% | ||
| Q3 24 | -20.9% | — | ||
| Q2 24 | 15.9% | — | ||
| Q1 24 | 23.5% | 81.3% |
| Q4 25 | $-12.85 | — | ||
| Q3 25 | $-11.35 | — | ||
| Q2 25 | $-6.88 | — | ||
| Q1 25 | $-4.91 | — | ||
| Q4 24 | $-13.64 | $2.01 | ||
| Q3 24 | $-12.39 | — | ||
| Q2 24 | $2.50 | — | ||
| Q1 24 | $5.99 | $3.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $66.1M | $418.9M |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $-626.4M | $675.3M |
| Total Assets | $2.8B | $744.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $66.1M | — | ||
| Q3 25 | $81.9M | — | ||
| Q2 25 | $100.0M | — | ||
| Q1 25 | $85.8M | — | ||
| Q4 24 | $112.9M | $418.9M | ||
| Q3 24 | $119.7M | — | ||
| Q2 24 | $121.8M | — | ||
| Q1 24 | $111.1M | $322.6M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.6B | — | ||
| Q2 25 | $2.6B | — | ||
| Q1 25 | $2.7B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 24 | $2.7B | — | ||
| Q2 24 | $2.8B | — | ||
| Q1 24 | $2.9B | — |
| Q4 25 | $-626.4M | — | ||
| Q3 25 | $-548.7M | — | ||
| Q2 25 | $-485.5M | — | ||
| Q1 25 | $-446.1M | — | ||
| Q4 24 | $-419.2M | $675.3M | ||
| Q3 24 | $-288.4M | — | ||
| Q2 24 | $-225.9M | — | ||
| Q1 24 | $-276.8M | $560.4M |
| Q4 25 | $2.8B | — | ||
| Q3 25 | $3.0B | — | ||
| Q2 25 | $3.1B | — | ||
| Q1 25 | $3.1B | — | ||
| Q4 24 | $3.2B | $744.7M | ||
| Q3 24 | $3.3B | — | ||
| Q2 24 | $3.3B | — | ||
| Q1 24 | $3.5B | $629.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-15.7M | $184.2M |
| Free Cash FlowOCF − Capex | $-86.8M | $182.8M |
| FCF MarginFCF / Revenue | -33.5% | 107.1% |
| Capex IntensityCapex / Revenue | 27.5% | 0.8% |
| Cash ConversionOCF / Net Profit | — | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | $-135.5M | $101.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-15.7M | — | ||
| Q3 25 | $5.5M | — | ||
| Q2 25 | $16.3M | — | ||
| Q1 25 | $-25.0M | — | ||
| Q4 24 | $-23.6M | $184.2M | ||
| Q3 24 | $795.0K | — | ||
| Q2 24 | $8.0M | — | ||
| Q1 24 | $-46.5M | $-27.4M |
| Q4 25 | $-86.8M | — | ||
| Q3 25 | $-226.0K | — | ||
| Q2 25 | $-3.6M | — | ||
| Q1 25 | $-44.8M | — | ||
| Q4 24 | $-131.6M | $182.8M | ||
| Q3 24 | $-21.8M | — | ||
| Q2 24 | $-22.9M | — | ||
| Q1 24 | $-80.4M | $-27.7M |
| Q4 25 | -33.5% | — | ||
| Q3 25 | -0.1% | — | ||
| Q2 25 | -1.2% | — | ||
| Q1 25 | -16.2% | — | ||
| Q4 24 | -47.8% | 107.1% | ||
| Q3 24 | -7.9% | — | ||
| Q2 24 | -7.2% | — | ||
| Q1 24 | -26.5% | -10.9% |
| Q4 25 | 27.5% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 6.6% | — | ||
| Q1 25 | 7.2% | — | ||
| Q4 24 | 39.2% | 0.8% | ||
| Q3 24 | 8.2% | — | ||
| Q2 24 | 9.8% | — | ||
| Q1 24 | 11.2% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.40× | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.16× | — | ||
| Q1 24 | -0.65× | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHT
| Occupancy | $190.2M | 73% |
| Food And Beverage | $51.8M | 20% |
| Hotel Other | $16.6M | 6% |
PTGX
Segment breakdown not available.
